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Abstract
BACKGROUND: We hypothesized a pro-inflammatory diet would be associated with higher 
prostate cancer (PC) risk.
METHODS: We prospectively recruited incident PC cases (n=254) and controls (n=328) at the 
Durham Veteran Affairs, from 2007–2018. From a self-completed 61-item Food Frequency 
Questionnaire, we calculated dietary inflammatory index (DII®) scores with and without 
supplements. We examined the association between DII scores with and without supplements and 
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overall PC risk using logistic regression and risk of low-grade PC (grade group 1) and high-grade 
PC (grade group 2–5) with multinomial logistic regression.
RESULTS: Cases were more likely to be Black (58% vs. 42%), had higher PSA (6.4 vs. 0.8 ng/
ml), lower BMI (29.1 vs. 30.6 kg/m2) and were older (64 vs. 62 years) versus controls (all 
p<0.01). Both black controls and cases had higher DII scores with and without supplements, 
though the DII scores with supplements in controls was not significant. On multivariable analysis, 
there were no associations between DII with or without supplements and overall PC risk (p-
trend=0.14, p-trend=0.09, respectively) or low-grade PC (p-trend=0.72, p-trend=0.47, 
respectively). Higher DII scores with (p-trend=0.04) and without supplements (p =0.08) were 
associated with high-grade PC, though the association for DII without supplements was not 
significant.
CONCLUSIONS: A pro-inflammatory diet was more common among Black men and associated 
with high-grade PC in our case-control study. The degree to which a pro-inflammatory diet 
contributes to PC race disparities warrants further study. If confirmed, studies should test whether 
a low inflammatory diet can prevent high-grade PC, particularly among Black men.
Keywords
prostate cancer; diet; dietary inflammatory index
INTRODUCTION
Prostate cancer (PC) is one of the most common cancers among men worldwide,1 including 
in the USA.2 Besides age, race and family history of PC, modifiable etiologic factors 
associated with PC risk are not well known. Diet encompasses a number of environmental 
factors that could influence the development of PC.3 However, the exact food constituents 
that increase or decrease risk remain unclear given often conflicting results in the literature 
(reviewed in4). An alternative to examining specific food constituents is to examine dietary 
patterns,5, 6 including ones that may play a role in modulating inflammation,7, 8 a potential 
mechanism associated with PC development.
Evidence suggests both systemic9 and prostatic inflammation10 may play a role in prostate 
carcinogenesis,11 and that diet plays a central part in the regulation of chronic inflammation. 
A Western-type diet high in red meat, high-fat dairy products, refined grains and simple 
carbohydrates has been associated with higher levels of inflammatory markers,12 whereas 
the Mediterranean diet, high in fruits and vegetables, omega-3 polyunsaturated fatty acids, 
fish and fiber has been linked to lower levels of inflammation.13 Given the potential role of 
inflammation in PC, this gives rise to the hypothesis that a pro-inflammatory diet may 
promote PC risk.
The dietary inflammatory index (DII®) was developed14 and validated15 to assess the 
overall quality of the diet with respect to its inflammatory potential. The DII was developed 
from a careful review and scoring of the scientific literature on diet and inflammation, and 
subsequently validated on a prospective observational study of healthy participants followed 
for 1 year.15, 16 Briefly, the DII represents a refined scoring algorithm based on extensive 
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review of the literature from 1950 to 2010 (10). Qualifying articles were scored according to 
whether each dietary parameter increased (+1), decreased (−1) or had no (0) effect on six 
inflammatory biomarkers: IL-1β, IL-4, IL-6, IL-10, TNF-α and C-reactive protein. Based on 
this search, the authors created a tool for assessing the inflammatory potential of the diet 
based on forty-five food parameters, that can be applied to any population in which dietary 
data have been collected.14
To date, several case-control studies17–21 and two prospective studies22, 23 examined the 
relationship between DII and PC risk. Among Italian,17, Iranian,18 Jamaican,19 Canadian,20 
Argentinian,21 and French men,22 a higher DII score was associated with a higher risk of 
PC, though the associations did not reach statistical significance in some studies and the 
number of men included was often quite small. However, none of the studies examined DII 
and PC aggressiveness with two exceptions, one was a case-control study among Mexican 
men, which found no associations between DII score and PC risk and aggressiveness.24 The 
second study among a prospective cohort of Californian men found a higher DII was 
associated with higher risk of high-grade PC, however they found a non-linear relationship, 
i.e. associations became null in the fourth quartile.23 Therefore, it is not clear whether the 
DII is associated with PC aggressiveness.
We examined the association between DII and PC risk in a case-control study of Black and 
White men at the Durham Veteran Affairs Medical Center. Furthermore, we assessed 
whether the intake of supplements modified this association. Given that inflammation is 
known to be more prevalent in Black men,10 we hypothesized that DII scores are higher in 
Black men and that the association between PC risk and DII is stronger in Black men 
compared to White men, but that higher DII would be associated with increased PC risk and 
aggressiveness in both races.
MATERIAL AND METHODS
Data Collection and Study Population
After receiving approval from the institutional review board and written informed consent 
from all men, we obtained data from an ongoing case-control study of men at the Durham 
Veterans Affair Medical Center (DVAMC). Methods for identification and accrual of 
participants have been described elsewhere.25, 26 Men were recruited between January 2007 
and January 2018 from the urology, internal medicine, and dermatology clinics at the 
DVAMC. Eligible men had no prior history of PC and had a prostate specific antigen (PSA) 
test in the year prior to enrollment.
Cases were selected from men who underwent biopsy and were found to have cancer. Cases 
were ascertained at the time of biopsy and thus not susceptible to post-diagnosis dietary 
changes often undertaken by people newly diagnosed with cancer.27, 28 Men were 
approached for enrollment prior to biopsy and most often completed questionnaires after the 
biopsy but prior to knowledge of the biopsy results. Of note, all questionnaires were self-
administered and median (IQR) time between biopsy and questionnaire completion was 3 
days (0,15). Given this timeframe, although the date on which men were informed of their 
biopsy results was not recorded, it is likely that only a subset of men knew their cancer 
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status before completing the questionnaire. Of the 1,617 men undergoing biopsy, 1,250 
(77% response rate) consented to participate in the study. Of the men undergoing biopsy, we 
only evaluated those with a positive biopsy for PC (n=656; 52% of biopsies).
Controls were similar to the cases, in that they had a PSA within a year and no history of 
PC. However, they were not recommended to undergo a biopsy. Of 1,149 controls screened, 
589 controls (51% response rate) consented.
A total of 652 cases and controls completed the food frequency questionnaire. Men with 
missing data on self-reported smoking history (n=45), caloric intake from the FFQ (n=3) or 
PSA (n=2) were excluded. Finally, we dropped men with extreme values of caloric intake 
(n=20) using Tukey fence’s approach (less than the 25th percentile – 1.5*interquartile range 
or greater than the 75th percentile + 1.5*interquartile range), resulting in a final study 
population of 582 men (Figure 1).
Height and weight were measured by trained personnel. Participants were asked to fill out 
the 61-item Harvard Food Frequency Questionnaire (FFQ),29 as well as a questionnaire 
detailing family, medical, and social history. All questionnaires were self-administered and 
either filled out the day of the biopsy or returned by mail usually prior to the patient 
knowing the biopsy outcome. From the FFQ, we calculated the dietary inflammatory index 
(DII) as described previously.14, 15 In brief, the DII is a weighted index of the degree to 
which the diet influences known serum inflammatory markers. Each food item is given a 
corresponding inflammatory score with the total DII representing the summed scores across 
all food parameters. It is modeled to create a symmetric distribution with values centered on 
0 with higher scores representing more inflammation. It has been subsequently validated in 
four studies among different populations showing strong correlations with a variety of serum 
inflammatory biomarkers.15, 30–34 The exactly methodology of how the DII was derived is 
explained in more detail in the DII Methods paper.14
Using the FFQ, we calculated the DII based on energy-adjusted intake of the 33 single food 
parameters of the 45 possible food parameters that were available from the FFQ using the 
energy density approach, which calculated the DII per 1000 kcal of energy.35 The 33 food 
parameters available for DII calculation in this study were vitamin B12, vitamin B6, β-
carotene, carbohydrate, cholesterol, fat, fibre, folic acid, iron, magnesium, monounsaturated 
fat acids (MUFA), niacin, protein, polyunsaturated fatty acids (PUFA), omega 3 and 6, 
riboflavin, saturated fat acids (SFA), selenium, thiamin, vitamin A, vitamin C, vitamin E, 
vitamin D, zinc, niacin, anthocyanidins, flavan3ol, flavones, flavonols, flavonones and 
caffeine. For the following parameters, supplement data were available in addition to the 
data from the normal diet: iron, zinc, vitamin C, B1, B2, B6, folate, Vitamin A, vitamin D, 
B12, Vitamin E, beta carotene, niacin, magnesium. On secondary analysis, we added 
supplement use to the DII calculation.
Statistical Analysis
Characteristics between cases and controls were compared using the Wilcoxon rank sum test 
for continuous variables and chi-squared test for categorical variables. Logistic regression 
was used to examine the association between DII scores with or without supplements and 
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PC diagnosis. Multinomial logistic regression was used to test the association between DII 
with or without supplements and low-grade PC (biopsy grade group 1) vs. no cancer and 
high-grade PC (biopsy grade group 2–5) vs. no cancer. DII was treated as a categorical 
variable divided into quartiles with cut-offs based on the controls. Models were fit 
unadjusted and adjusted for age (continuous), race (Black vs. Non-Black), BMI 
(continuous), smoking history (current/former smoker vs. never-smoker), and daily caloric 
intake (continuous).
The interaction between DII with or without supplements, BMI, and race to assess the 
association with PC diagnosis was tested by including the main effects and cross product 
term in the multivariable logistic regression. Analyses were performed using SAS® 9.4 
(SAS Institute, Inc. Cary, NC). Statistical significance was two-sided with a threshold of 
p<0.05. Code availability: TO, LEH.
RESULTS
Patient Characteristics
The study cohort consisted of 328 (56%) controls and 254 (44%) cases (Table 1). Of the 
cases, 53% were high-grade (biopsy grade groups 2–5). Cases were more likely to be Black 
(58% vs. 42%, p<0.001), had higher PSA (6.4 vs. 0.8 ng/ml, p<0.001), had lower BMI (29.1 
vs. 30.6 kg/m2, p<0.01), and were older (64 vs. 62 years, p<0.001) compared to controls. 
There was no difference in smoking history, daily caloric intake, or DII with or without 
supplements (all p>0.15). DII scores, with and without supplements, were higher in Black 
men compared to White men, both in controls and PC cases (Table 2). In a sub-analysis 
among controls, we found DII was not correlated with PSA (data not shown). There was no 
collinearity between race and DII (ρ =−0.16, for race and DII with supplements; ρ =−0.12, 
for race and DII without supplements).
Primary Analysis: DII and overall PC Risk
On univariable analysis, there was no association between DII with or without supplements 
and overall PC diagnosis [both p-trend ≥0.18] (Table 3). There remained no association 
between DII with or without supplements and overall PC risk (both p-trend ≥ 0.09), after 
multivariable adjustment. No interaction was found between DII score with supplements and 
BMI (p-interaction=0.87) and race (p-interaction=0.79) in assessing the association with 
overall PC diagnosis. Similar results were obtained when the interactions between DII 
without supplements and BMI (p-interaction=0.61) and between DII without supplement 
and race (p-interaction=0.36) were tested.
Secondary Analysis: DII and low- and high-grade PC Risk
DII scores with supplements was not associated with risk of low-grade PC (p-trend=0.83), 
on unadjusted analysis (Table 3). Likewise, DII without supplements was not associated 
with risk of low-grade PC (p-trend=0.86). After adjustment for known potential 
confounders, there remained no association between DII with (p-trend=0.72) or without (p-
trend=0.47) supplements and risk of low-grade PC. Regarding high-grade disease, on 
unadjusted analysis, each quartile of higher DII with supplements was associated with 
Vidal et al. Page 5
Prostate Cancer Prostatic Dis. Author manuscript; available in PMC 2019 November 16.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
increasing risk of high-grade disease, though the overall association approached, but did not 
reach, statistical significance (p-trend=0.06). After adjustment for confounders, higher DII 
scores with supplements were associated with statistically significantly increased risk of 
high-grade PC (p-trend=0.04). While overall similar patterns were seen for DII without 
supplements and high-grade PC, all associations were not statistically significant (p-
trend=0.21 for unadjusted and p-trend=0.08 for adjusted analyses). Similar to the primary 
analysis, there was no interaction between race and DII (with or without supplements) when 
assessing the risk of low- or high-grade PC (all p-interactions >0.24).
DISCUSSION
Evidence suggests that both systemic9 and prostatic inflammation36 are linked to prostate 
carcinogenesis, and diet may have an influence on this association.36, 37 Indeed, some 
nutrients have been shown to have a pro-inflammatory (e.g. carbohydrates, cholesterol, etc.
38) while others (e.g. isoflavone, caffeine, garlic, omega-3 fats, soya, etc.39, 40 have an anti-
inflammatory effect. Hence, we used a DII exclusively developed to assess the inflammatory 
index of dietary intakes among men at the Durham VA Medical Center in the USA, where 
58% of PC cases were Black men. As we hypothesized, Black men had higher DII scores 
than White men. Among all men, higher DII was associated with a higher risk of high-grade 
PC compared to controls (results only reached significance for DII with supplements). 
However, we found no associations between DII with or without supplements and overall or 
low-grade PC risk. Contrary to our hypothesis, we found no interaction between race and 
DII with or without supplements in predicting overall PC diagnosis. If confirmed in larger 
cohorts, future studies should test the anti-PC activity of an anti-inflammatory diet, 
especially in Black men.
Several studies reported on the associations between specific diets and PC,3 and although 
seven studies analyzed the link between DII and PC risk in different cohorts of men around 
the globe17–24 including U.S. men. For the present study, we used the same DII score as 
used in those seven studies.14
Among the studies that previously assessed the association between DII and PC risk, six 
were case-control studies17–21, 24 and two were prospective studies.22, 23 In 2,745 Italian 
men (PC cases=1,294), a higher DII, either used as a continuous or categorical variable was 
associated with an increased risk of PC.17 Similarly, Canadian men (72 PC cases/302 
controls) with higher DII scores were at increased risk of PC using DII score both as a 
continuous and categorical variable.20 In a case–control study of 462 Argentinian males (PC 
cases=153), a higher DII score was associated with increased odds of PC, this effect was 
more pronounced among obese.21 In other studies, among Iranian (60 PC cases/60 controls; 
p-trend=0.15),18 Jamaican (229 PC cases/250 controls; p-trend=0.08),19 and French men 
(PC cases=123, prospective study; p-trend=0.20),22 though a higher DII score showed a 
trend for an association with higher PC risk, results were not significant, as also shown in a 
recent pooled analysis.41 Whether this lack of significance reflects a true lack of association 
or small sample sizes is unclear. We found similar results to these latter studies among U.S. 
veterans: non-significant associations, though the direction of the associations favored 
higher DII and higher PC risk. Of note, the ORs in our study were modest but potentially 
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clinically important, if validated, for the highest vs. lowest quartile (OR 1.53–1.57). The 
largest study to date, though, found no associations between higher DII and overall PC risk, 
even when analyses were stratified by race.23 As such, future larger studies or a meta-
analysis of the published studies is needed to better examine the potential modest, but 
clinically relevant possibility that a high inflammatory diet is associated with increased PC 
risk.
While we found overall null associations for low-grade disease, the association between DII 
and risk of high-grade PC was evident. However, only the association between DII with 
supplements and high-grade PC was statistically significant (p-trend=0.04), after adjusting 
for confounders. There are only two other studies that tested the link between DII and PC 
grade. A case-control study among Mexican men (394 PC cases/794 controls), found, 
similar to our study, a weak and non-significant suggestion that higher DII scores were 
correlated with increased PC risk and aggressiveness (p-trend=0.14).24 In a prospective 
cohort of 40,161 from the California Men’s Health Study (CMHS), a higher DII (3rd Q) was 
associated with higher risk of high-grade PC, however this association became null in the 
fourth Q, p-trend=0.74, suggesting a non-linear dose-response.23 As such, our results and 
those of the prior study among Mexican men did not reach statistical significance (except 
DII with supplements on multivariable analysis in our study), these studies found very 
similar results – trends toward increased risk of high-grade PC with higher DII scores. 
Again, larger studies or a formal meta-analysis of the published studies are needed to better 
examine this issue.
Several reasons may explain the small discrepancy among the various studies. First, the DII 
calculation in the present study was based on 33-food parameters compared to the 31-food 
parameters used to calculate DII scores in the Italian case-control study.17 Second, the FFQ 
used in the Italian study included 78 foods and beverages as well as a range of the most 
common Italian recipes, whereas our study used a 61 item FFQ 29 of the most common 
foods consumed in the USA. Third, our study included White and Black men, compared to 
only White men in the Italian study, and although we did not observe statistically significant 
differences by race in the association between DII and PC risk, the discrepant results may 
have been influenced by this racial distribution. The Canadian study used 18-food 
parameters from their 67-item FFQ to develop the DII score, and while the food items are 
probably similar to the ones consumed in the U.S., it was limited by only having 72 PC 
cases which may explain the broad confidence intervals when DII was used as a categorical 
variable (OR=3.50, 95% CI 1.25–9.80).20 However, our results are in complete agreement 
with the Iranian (21-food parameters),18 French (36-food parameters),22 and Jamaican (21-
food parameters),19 studies, where a trend in the association was found between higher DII 
and overall PC risk, though this did not reach statistical significance in our study or any of 
these latter studies.
Considering that all studies found either significantly increased PC risk with higher DII or 
non-significant trends in that direction, these results do support the hypothesis that a pro-
inflammatory diet, measured by the DII, may play a role in PC risk – especially aggressive 
PC. The link between inflammation and PC is supported by evidence from studies showing a 
positive association between higher concentrations of inflammatory biomarkers and 
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increased risk of PC.9, 42, 43 Likewise, the use of NSAIDs is associated with a reduced risk 
of PC.44 A pro-inflammatory diet may be linked to increased PC risk through components of 
the metabolic syndrome. We previously found that components of the metabolic syndrome 
were associated with a higher risk of PC among men undergoing biopsy.45 A higher DII 
score also was associated with glucose intolerance,32 indicating that glucose intolerance and 
insulin resistance may lead to PC through the growth-promoting effects of the IGF-1/
IGF-1R/insulin pathway.46 Given that previous studies showed Black men are more 
hyperinsulinemic and insulin resistant when compared to White men,47, 48 our present 
results showing that Black men had higher DII scores than White men are in agreement with 
those data. Taking together this evidence may explain why Black men present with more 
aggressive PC at diagnosis,49 even though our study was not sufficiently powered to observe 
a racial difference in the association between higher DII score and risk of high-grade PC. 
The only other study that included Black men, found that race modified the association 
between DII score and high-grade PC. In Black men with high-grade PC the DII score was 
higher in Q2 and increased fourfold in Q3.23 As mentioned above, future studies should test 
whether an anti-inflammatory diet, especially in Black men could reduce PC risk, including 
high-grade PC.
Strengths of our study include its multiethnic nature, which included 58% Black cases, and 
the use of a novel DII score to assess the potential inflammatory effect of a Western diet in 
relation to PC risk. Limitations include the fact that the sample size was not large thus DII 
quartile numbers were relatively small. Controls were recruited from out-patients seen in a 
hospital setting. Thus, the diet and comorbidities of these controls may not be representative 
of the general population. FFQs, including the one we used, may not be optimal to capture 
the true range of DII and its variability over time, and we cannot exclude the possibility of 
recall bias. We did not have data on frequency, dose, and duration of supplements used and 
we merely captured use (yes/no) at the time of study enrollment. However, most cases 
completed questionnaires prior to the biopsy when they did not know whether they had PC 
or not minimizing concerns over diet behavior modification bias due to diagnosis. We found 
black men had higher DII scores and we previously showed in this cohort that black men 
were more likely to have high-grade PC.50 While there was no collinearity between DII and 
race, given our small sample size, we cannot easily distinguish which is driving these 
effects. However, there was no interaction between race and DII for predicting high-grade 
PC suggesting high DII is linked with PC independent of race, though more studies in 
multiracial cohorts are needed. In summary, our findings suggest a pro-inflammatory diet 
may be associated with increased high-grade PC risk in our case-control study. Future 
studies are needed to confirm these findings and understand the role of supplements on 
inflammation and PC risk. If results are confirmed, this would support future studies testing 
whether a low-inflammatory diet can decrease the risk of high-grade PC, especially among 
Black men.
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Figure 1: 
Consort diagram of final sample used for analysis
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Table 1:
Baseline characteristics for biopsy-positive patients (cases) and controls.
Cases (N=254) Controls (N=328) p value
Age <0.001
 Median (IQR) 64 (60, 68) 62 (58,66)
Race <0.001
 White 106 (42) 231 (70)
 Black 148 (58) 97 (30)
Daily calorie intake 0.65
 Median (IQR) 1599.2(1230.9, 2196.0) 1696.9(1220.1, 2232.7)
DII with supplements (continuous) 0.15
 Median (IQR) 0.8 (−1.7, 2.9) 0.3 (−2.2, 2.6)
DII with supplements (quartiles) 0.18
 Q1 90 (27) 57 (23)
 Q2 84 (25) 61 (24)
 Q3 74 (23) 70 (27)
 Q4 80 (24) 66 (26)
DII without supplements 0.45
 Median (IQR) 1.6 (−0.7, 3.5) 1.2 (−1.3, 3.7)
DII without supplements (quartiles) 0.37
 Q1 92 (28) 55 (22)
 Q2 77 (23) 68 (27)
 Q3 74 (23) 71 (27)
 Q4 85 (26) 60 (24)
PSA (ng/mL)
 Median (IQR) 6.4 (4.9, 8.6) 0.8 (0.5, 1.5) <0.001
BMI (kg/m2)
 Median (IQR) 29.1 (25.8, 32.6) 30.6 (27.1, 33.8) 0.003
Current or former smoker? 0.62
 No 80 (32) 97 (30)
 Yes 174 (68) 231 (70)
Biopsy Grade group
 1 119 (47) -
 2–5 135 (53) -
BMI = body mass index, DII= Dietary Inflammatory Index, PSA = prostate-specific antigen, IQR= Interquartile range.
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Table 3:
Odds ratios and 95% confidence intervals for risk of overall, low-grade, and high-grade PCA relative to no PC 
based on biopsy-positive patients versus controls.
Unadjusted Multivariable*
N1/N0 OR (95% CI) p-value OR (95% CI) p-value
Overall PC (n=254)
DII with supplements
 Q1 57/90 Reference 0.18 Reference 0.14
 Q2 61/84 1.15 (0.72–1.83) 1.57 (0.93–2.64)
 Q3 70/74 1.49 (0.94–2.38) 1.61 (0.94–2.76)
 Q4 66/80 1.30 (0.82–2.07) 1.57 (0.85–2.88)
Low-Grade PC (n=119)
DII with supplements
 Q1 31/90 Reference 0.83 Reference 0.72
 Q2 26/84 0.90 (0.49–1.64) 1.23 (0.64–2.35)
 Q3 36/74 1.41 (0.80–2.50) 1.46 (0.77–2.79)
 Q4 26/80 0.94 (0.52–1.72) 1.06 (0.50–2.27)
High-Grade PC (n=135)
DII with supplements
 Q1 26/90 Reference 0.06 Reference 0.04
 Q2 35/84 1.44 (0.80–2.60) 1.99 (1.05–3.77)
 Q3 34/74 1.59 (0.87–2.89) 1.77 (0.91–3.47)
 Q4 40/80 1.73 (0.97–3.09) 2.23 (1.07–4.65)
Overall PC (n=254)
DII without supplements
 Q1 55/92 Reference 0.36 Reference 0.09
 Q2 68/77 1.48 (0.93–2.36) 1.45 (0.86–2.45)
 Q3 71/74 1.61 (1.01–2.56) 1.91 (1.07–3.41)
 Q4 60/85 1.18 (0.74–1.89) 1.53 (0.72–3.23)
Low-Grade PC (n=119)
DII without supplements
 Q1 26/92 Reference 0.86 Reference 0.47
 Q2 34/77 1.56 (0.86–2.83) 1.51 (0.79–2.90)
 Q3 37/74 1.77 (0.98–3.18) 1.96 (0.95–4.03)
 Q4 22/85 0.92 (0.48–1.74) 1.06 (0.40–2.80)
High-Grade PC (n=135)
DII without supplements
 Q1 29/92 Reference 0.21 Reference 0.08
 Q2 34/77 1.40 (0.78–2.50) 1.39 (0.73–2.63)
Prostate Cancer Prostatic Dis. Author manuscript; available in PMC 2019 November 16.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Vidal et al. Page 16
Unadjusted Multivariable*
N1/N0 OR (95% CI) p-value OR (95% CI) p-value
 Q3 34/74 1.46 (0.81–2.61) 1.84 (0.91–3.74)
 Q4 38/85 1.42 (0.81–2.50) 2.01 (0.83–4.87)
Abbreviations: PC: Prostate cancer, OR: Odds ratio; CI: confidence interval
*Adjusted for age, race, BMI, smoking history, and daily caloric intake, Q1, Q2, Q3 and Q4 are quartiles of DII with and without supplements.
§p-value for trend calculated by entering the median value of DII for each quartile of DII into the model as a continuous variable.
N0: controls; N1: represents the number of men diagnosed with prostate cancer, low-grade or high-grade prostate cancer, respectively within each 
quartile of DII (with or without supplement)
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